Gastroenterology

Julius Middleton Wilder, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Box 90120, Durham, NC 27708-0120
Phone (919) 684-8111
Email address julius.wilder@duke.edu
In Their Words

Education and Training

  • Transplant Hepatology Fellowship, Medicine, Duke University School of Medicine, 2015 - 2016
  • DCRI Research Fellowship, Duke University School of Medicine, 2013 - 2016
  • Gastroenterology Fellowship, Medicine, Duke University School of Medicine, 2012 - 2015
  • Internal Medicine Residency, Medicine, Duke University School of Medicine, 2008 - 2011
  • M.D., Duke University School of Medicine, 2008
  • Ph.D., Duke University, 2007

Grants

Publications

Ward, Rachael A., Teminioluwa Ajayi, Tanya Aylward, Jennifer Byrns, Bryant B. Summers, and Julius Wilder. “Multi-disciplinary approach to perioperative risk assessment and post-transplant management for liver transplantation in a patient at risk for Brugada syndrome..” J Perioper Pract 29, no. 5 (May 2019): 140–46. https://doi.org/10.1177/1750458918796013.

PMID
30212282
Full Text

Wilder, Julius, Steve S. Choi, and Cynthia A. Moylan. “Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis..” Jama 320, no. 19 (November 2018): 2031–32. https://doi.org/10.1001/jama.2018.13073.

PMID
30383175
Full Text

Spann, Ashley, Shakirat Salvador, Talisha Ramchal, Diana Mosquera, Joshua P. Lee, Lauren Donnangelo, Aaron Hein, Omar Martinez-Uribe, and Julius Wilder. “Prognostic Utility of Ammonia Testing on Admission in Cirrhotic Patients with and without Acute on Chronic Liver Failure (ACLF).” In Hepatology, 68:1344A-1345A. WILEY, 2018.

Scholars@Duke

Muir, Andrew Joseph, Jia Yao, Julius Wilder, Christina Makarushka, Kelly Keefe, James Henry Helzberg, Paolo Mannelli, et al. “The Alcohol Use Disorders Identification Test Screening in Patients with Hepatitis C.” In Hepatology, 68:908A-908A. WILEY, 2018.

Scholars@Duke

Patel, Yuval, Jacqueline Henson, Julius Wilder, Matthew R. Kappus, Andrew S. Barbas, Cynthia A. Moylan, Donna Niedzwiecki, Andrew Joseph Muir, and Carl L. Berg. “The Impact of Advanced Age on Waiting List and Post-Transplantation Outcomes for NAFLD Patients.” In Hepatology, 68:683A-683A. WILEY, 2018.

Scholars@Duke

Helzberg, James H., Alice Parish, Donna Niedzwiecki, Charles Y. Kim, Julius M. Wilder, and Andrew J. Muir. “TIPS Outcomes According to Race and Ethnicity.” In American Journal of Gastroenterology, 113:S496–S496. NATURE PUBLISHING GROUP, 2018.

Scholars@Duke

Patel, Yuval A., Jacqueline B. Henson, Julius M. Wilder, Jiayin Zheng, Schein-Chung Chow, Carl L. Berg, Stuart J. Knechtle, and Andrew J. Muir. “The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis..” Clin Transplant 32, no. 10 (October 2018). https://doi.org/10.1111/ctr.13388.

PMID
30136315
Full Text

Proeschold-Bell, Rae Jean, Donna M. Evon, Christina Makarushka, John B. Wong, Santanu K. Datta, Jia Yao, Ashwin A. Patkar, et al. “The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial..” Contemp Clin Trials 72 (September 2018): 73–85. https://doi.org/10.1016/j.cct.2018.07.003.

PMID
30006024
Full Text

Clement, Meredith E., Lauren F. Collins, Julius M. Wilder, Michael Mugavero, Taryn Barker, and Susanna Naggie. “Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure..” Infect Dis Clin North Am 32, no. 2 (June 2018): 407–23. https://doi.org/10.1016/j.idc.2018.02.005.

PMID
29778263
Full Text

Pages